Holen Sie sich die Stockscreener-App
0.2927
1.39%
0.00515
Hepion Pharmaceuticals Inc Aktie (HEPA) Neueste Nachrichten
Press Release Distribution & PR Platform - ACCESS Newswire
Holdings of Hepion Pharmaceuticals Inc (HEPA) are aligned with the stars - Sete News
Hepion Pharmaceuticals (NASDAQ:HEPA) Stock Price Down 2% – What’s Next? - Defense World
Hepion Pharmaceuticals (HEPA) Ends Merger with Pharma Two B - GuruFocus
Hepion Pharmaceuticals (HEPA) Announces $9M Public Offering Laun - GuruFocus
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Hepion Pharmaceuticals to Present at the First Annual BioTuesdays Pre-JPM Virtual Conference - ACCESS Newswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Pharma Two B Presents Positive P2B001 Data for Parkinson's Disea - GuruFocus
Hepion Pharmaceuticals (HEPA) to Implement 1-for-50 Reverse Stoc - GuruFocus
Hepion Pharmaceuticals, Inc. SEC 10-K Report - TradingView
HEPA stock touches 52-week low at $0.39 amid sharp annual decline - Investing.com Canada
Before You Invest, Make Sure You Check This Hepion Pharmaceuticals Inc (NASDAQ: HEPA) Analysis - Stocksregister
Hepion Pharmaceuticals Delays Annual Report Filing - TipRanks
Hepion Pharmaceuticals announces 1-for-50 reverse stock split - MSN
HEPA stock plunges to 52-week low, touches $0.67 By Investing.com - Investing.com UK
Hepion Pharmaceuticals (NASDAQ:HEPA) Stock Price Down 7.2% – Here’s Why - Defense World
Hepion Pharmaceuticals faces potential Nasdaq delisting By Investing.com - Investing.com South Africa
Hepion Pharmaceuticals faces potential Nasdaq delisting - Investing.com
Hepion Pharmaceuticals enacts reverse stock split By Investing.com - Investing.com India
Hepion Pharmaceuticals enacts reverse stock split - Investing.com
Hepion Pharmaceuticals Announces 1-for-50 Reverse Stock Split Effective March 17, 2025 - Nasdaq
Upcoming Stock Splits This Week (March 17 to March 21) – Stay Invested - The Globe and Mail
Hepion Pharmaceuticals Announces 1-for-50 Reverse Stock Split - ROI-NJ.com
Hepion Pharmaceuticals Announces 1-for-50 Reverse Stock Split To Maintain Nasdaq Listing - Nasdaq
Hepion Pharmaceuticals enacts reverse stock split to meet NASDAQ requirements - Investing.com Australia
Hepion Pharmaceuticals enacts reverse stock split to meet NASDAQ requirements By Investing.com - Investing.com South Africa
Hepion Pharmaceuticals Announces Reverse Stock Split - citybiz
Hepion Plans Massive 1:50 Reverse Split to Save NASDAQ ListingWhat Shareholders Must Know - StockTitan
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Why Intel Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Benzinga India
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Pre-market Movers: HCTI, HEPA, ZYXI, SYRS ... - RTTNews
An In-Depth Look At Hepion Pharmaceuticals Inc (HEPA) - Marketing Sentinel
HEPA stock plunges to 52-week low, touches $0.08 - Investing.com Australia
HEPA stock plunges to 52-week low, touches $0.08 By Investing.com - Investing.com South Africa
Hepion Pharmaceuticals releases unaudited balance sheet - Investing.com India
Hepion Pharmaceuticals Announces Publication in Expert Opinion on Investigational Drugs - ACCESS Newswire
HEPA stock touches 52-week low at $0.12 amid sharp decline - Investing.com Canada
Hepion Pharmaceuticals Successfully Advances to Next Dosing Level in Ongoing Multiple Ascending Dose Clinical Study of CRV431 - ACCESS Newswire
Hepion Pharmaceuticals (NASDAQ:HEPA) Shares Up 1.3% – Here’s Why - Defense World
The HEPA Stock Puzzle: Unraveling Hepion Pharmaceuticals Inc’s Fluctuating Performance - The InvestChronicle
0.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):